Breathe Well Live Well
|
How often should asthma be assessed?
Clinical Advisor The key is to "treat up" the asthma scale, and consider stepping down once stabilized. For example, if someone diagnosed with mild intermittent asthma develops increasing symptoms that meet the criteria for moderate persistent asthma, treatment must be … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: CHF1535 pMDI + AC Plus; Drug: BDP + AC Plus; Drug: Formoterol + AC Plus
Sponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.
Completed – verified May 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: CHF1535 pMDI + AC Plus; Drug: BDP and Formoterol + AC Plus
Sponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.
Completed – verified April 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Smartphone apps for vaccines, asthma generate interest at NAPNAP 2013
Clinical Advisor … CPNP-AC, and Jodi Shroba RN, MSN, CPNP, both of Children's Mercy Hospitals and Clinics in Kansas City, Miss., touted the benefits of apps to improve health literacy among patients with chronic asthma and allergies to enable better self-management. |
View full post on asthma – Google News
| Related Articles |
Is Clinical Judgment of Asthma Control Adequate?: A prospective survey in a tertiary hospital pulmonary clinic.
Sultan Qaboos Univ Med J. 2013 Feb;13(1):63-8
Authors: Baddar S, Jayakrishnan B, Al-Rawas O, George J, Al-Zeedy K
Abstract
OBJECTIVES: Asthma control is often difficult to measure. The aim of this study was to compare physicians’ personal clinical assessments of asthma control with the Global Initiative for Asthma (GINA) scoring.
METHODS: Physicians in the adult pulmonary clinics of a tertiary hospital in Oman first documented their subjective judgment of asthma control on 157 consecutive patients. Immediately after that and in the same proforma, they selected the individual components from the GINA asthma control table as applicable to each patient.
RESULTS: The same classification of asthma control was achieved by physicians’ clinical judgment and GINA classification in 106 cases (67.5%). In the other 32.5% (n = 51), the degree of control by clinical judgment was one level higher than the GINA classification. The agreement was higher for the pulmonologists (72%) as compared to non-pulmonologists (47%; P = 0.009). Physicians classified 76 patients (48.4%) as well-controlled by clinical judgment compared to 48 (30.6%) using GINA criteria (P <0.001). Conversely, they classified 34 patients (21.7%) as uncontrolled as compared to 57 (36.3%) by GINA criteria (P <0.001). In the 28 patients who were clinically judged as well-controlled but, by GINA criteria, were only partially controlled, low peak expiratory flow rate (PEFR) (46.7%) and limitation of activity (21.4%) were the most frequent parameters for downgrading the level of control.
CONCLUSION: Using clinical judgment, physicians overestimated the level of asthma control and underestimated the uncontrolled disease. Since management decisions are based on the perceived level of control, this could potentially lead to under-treatment and therefore sub-optimal asthma control.
PMID: 23573384 [PubMed – in process]
View full post on pubmed: asthma
|
The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study …
PR Newswire (press release) Cytos Biotechnology Ltd (SIX:CYTN) today announced the publication of the results from its phase 2a clinical trial with CYT003-QbG10 (CYT003), a first-in-class immune modulator in clinical development as a potential new treatment for allergic asthma. |
View full post on asthma – Google News
|
Pesticides, antibacterials linked to asthma Rxs
Clinical Advisor Those in the highest tertiary of urinary 2,5-dichlorophenol concentration had a significantly higher probability of taking a prescription medication for asthma-related wheezing (P=0.02) than those in the second or lowest tertiaries, Elina Jerschow, MD … |
View full post on asthma – Google News
|
Aerocrine: UK clinical study demonstrates that asthma tests can identify non …
Business Wire (press release) SOLNA, Sweden–(BUSINESS WIRE)–Aerocrine AB (OMX Nordic Exchange: AERO) announces that a clinical trial published in The American Journal of Respiratory and Critical Care Medicine shows that FeNO-testing is an excellent tool to identify patients … |
View full post on asthma – Google News
|
Aerocrine: UK clinical study demonstrates that asthma tests can identify non …
The Herald | HeraldOnline.com SOLNA, Sweden — Aerocrine AB (OMX Nordic Exchange: AERO) announces that a clinical trial published in The American Journal of Respiratory and Critical Care Medicine shows that FeNO-testing is an excellent tool to identify patients that don't adhere to … |
View full post on asthma – Google News
|
Aerocrine: UK clinical study demonstrates that asthma tests can identify non …
Fort Mills Times Aerocrine AB (OMX Nordic Exchange: AERO) announces that a clinical trial published in The American Journal of Respiratory and Critical Care Medicine shows that FeNO-testing is an excellent tool to identify patients that don't adhere to treatment. |
View full post on asthma – Google News